Search Results - "van Hout, Ben"

Refine Results
  1. 1

    Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ‐5D‐5L value functions on societal, group and individual level by Schneider, Paul, Devlin, Nancy, Hout, Ben, Brazier, John

    Published in Health economics (01-05-2024)
    “…A new method has recently been developed for valuing health states, called ‘Online elicitation of Personal Utility Functions’ (OPUF). In contrast to…”
    Get full text
    Journal Article
  2. 2

    A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol by Oppe, Mark, PhD, Devlin, Nancy J., PhD, van Hout, Ben, PhD, Krabbe, Paul F.M., PhD, de Charro, Frank, PhD

    Published in Value in health (01-06-2014)
    “…Abstract Objectives To describe the research that has been undertaken by the EuroQol Group to improve current methods for health state valuation, to summarize…”
    Get full text
    Journal Article
  3. 3

    Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets by van Hout, Ben, PhD, Janssen, M.F., PhD, Feng, You-Shan, PhD, Kohlmann, Thomas, PhD, Busschbach, Jan, PhD, Golicki, Dominik, MD, Lloyd, Andrew, PhD, Scalone, Luciana, PhD, Kind, Paul, MPhil, Pickard, A. Simon, PhD

    Published in Value in health (01-07-2012)
    “…Abstract Background A five-level version of the EuroQol five-dimensional (EQ-5D) descriptive system (EQ-5D-5L) has been developed, but value sets based on…”
    Get full text
    Journal Article
  4. 4

    Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain by Villa, Guillermo, PhD, Lothgren, Mickael, PhD, Kutikova, Lucie, PhD, Lindgren, Peter, PhD, Gandra, Shravanthi R., PhD, Fonarow, Gregg C., MD, Sorio, Francesc, MSc, Masana, Lluis, MD, PhD, Bayes-Genis, Antoni, MD, PhD, Hout, Ben van, PhD

    Published in Clinical therapeutics (01-04-2017)
    “…Abstract Purpose Our objective was to assess the cost-effectiveness of evolocumab in patients at high risk of cardiovascular (CV) events from the Spanish…”
    Get full text
    Journal Article
  5. 5

    Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review by Bunge, Eveline M, van Hout, Ben, Haas, Sylvia, Spentzouris, Georgios, Cohen, Alexander

    Published in BMJ open (01-02-2021)
    “…ObjectiveTo critically appraise the published comparative effectiveness studies on non-vitamin K antagonist oral anticoagulants (NOACs) in non-valvular atrial…”
    Get full text
    Journal Article
  6. 6

    Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy by Rowen, Donna, PhD, Mulhern, Brendan, MRes, Banerjee, Sube, FRCPsych, van Hout, Ben, PhD, Young, Tracey A., PhD, Knapp, Martin, PhD, Smith, Sarah C., PhD, Lamping, Donna L., PhD, Brazier, John E., PhD

    Published in Value in health (01-03-2012)
    “…Abstract Objective Although condition-specific measures are commonly used in dementia, they cannot be used in analyses of cost per quality-adjusted life-year…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Valuing health‐related quality of life: An EQ‐5D‐5L value set for England by Devlin, Nancy J., Shah, Koonal K., Feng, Yan, Mulhern, Brendan, Hout, Ben

    Published in Health economics (01-01-2018)
    “…A new version of the EQ‐5D, the EQ‐5D‐5L, is available. The aim of this study is to produce a value set to support use of EQ‐5D‐5L data in decision‐making. The…”
    Get full text
    Journal Article
  9. 9

    Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol by Stolk, Elly, Ludwig, Kristina, Rand, Kim, van Hout, Ben, Ramos-Goñi, Juan Manuel

    Published in Value in health (01-01-2019)
    “…A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set…”
    Get full text
    Journal Article
  10. 10

    Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK by Clay, Emilie, Jamotte, Aurélien, Verhamme, Peter, Cohen, Alexander T., Van Hout, Ben. A., Gumbs, Pearl

    “…Background: Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common acute cardiovascular…”
    Get full text
    Journal Article
  11. 11

    Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA by Wassenberg, Marjan W M, de Wit, G Ardine, van Hout, Ben A, Bonten, Marc J M

    Published in PloS one (16-07-2010)
    “…The costs and benefits of controlling nosocomial spread of antibiotic-resistant bacteria are unknown. We developed a mathematical algorithm to determine…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Mapping EQ-5D-3L to EQ-5D-5L by van Hout, Ben A., Shaw, James W.

    Published in Value in health (01-09-2021)
    “…The original 3-level EQ-5D (EQ-5D-3L) includes 5 dimensions with 3 levels of problems per dimension. Since 2010, a more sensitive version with 5 levels of…”
    Get full text
    Journal Article
  14. 14

    A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale by Rowen, Donna, Brazier, John, Van Hout, Ben

    Published in Medical decision making (01-04-2015)
    “…Background. Preference elicitation techniques such as time trade-off (TTO) and standard gamble (SG) receive criticism for their complexity and difficulties of…”
    Get full text
    Journal Article
  15. 15

    Prevalence and incidence of severe sepsis in Dutch intensive care units by van Gestel, Aukje, Bakker, Jan, Veraart, Christiaan P W M, van Hout, Ben A

    Published in Critical care (London, England) (01-08-2004)
    “…Severe sepsis is a dreaded consequence of infection and necessitates intensive care treatment. Severe sepsis has a profound impact on mortality and on hospital…”
    Get full text
    Journal Article
  16. 16

    Cost-effectiveness of additional blood screening tests in the Netherlands by Borkent-Raven, Barbara A., Janssen, Mart P., van der Poel, Cees L., Bonsel, Gouke J., van Hout, Ben A.

    Published in Transfusion (Philadelphia, Pa.) (01-03-2012)
    “…BACKGROUND: During the past decade, blood screening tests such as triplex nucleic acid amplification testing (NAT) and human T‐cell lymphotropic virus type I…”
    Get full text
    Journal Article
  17. 17

    The EQ-5D-5L Value Set for England: Response to the “Quality Assurance” by van Hout, Ben, Mulhern, Brendan, Feng, Yan, Shah, Koonal, Devlin, Nancy

    Published in Value in health (01-05-2020)
    “…To respond to the ‘quality assurance’ of the EQ-5D-5L value set for England study. We provide a point-by-point response to the issues raised by the authors of…”
    Get full text
    Journal Article
  18. 18

    Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections by Logman, J. Floris S., Stephens, Jennifer, Heeg, Bart, Haider, Seema, Cappelleri, Joseph, Nathwani, Dilip, Tice, Alan, van Hout, Ben A.

    Published in Current medical research and opinion (01-07-2010)
    “…Abstract Objective: With a growing number of studies and comparators in MRSA skin infections, a unified framework for comparing treatments is needed for health…”
    Get full text
    Journal Article
  19. 19

    Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences by Powell, Philip A., Karimi, Milad, Rowen, Donna, Devlin, Nancy, van Hout, Ben, Brazier, John E.

    Published in Quality of life research (01-04-2023)
    “…Objectives Responses from hypothetical and experienced valuation tasks of health-related quality of life differ, yet there is limited understanding of why…”
    Get full text
    Journal Article
  20. 20